marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2023-Q1
hinzugefügt 11.05.2023
TCR2 Therapeutics Bilanz 2011-2024 | TCRR
Bilanz Jährlich TCR2 Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-7.6 M | -196 M | -94.2 M | -65.3 M | -47.7 M | -19.8 M | -7.99 M | - | - | - | - | - |
Langfristige Schulden |
3.32 M | 23 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
21.8 M | 3.37 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | 807 K | 546 K | 210 M | 47.1 M | 29.2 M | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
64.1 M | 18.6 M | 8.84 M | 7.53 M | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
67.4 M | 41.9 M | 9.65 M | 8.08 M | 215 M | 48.4 M | 30.1 M | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-501 M | -350 M | -250 M | -183 M | -85.6 M | -26.3 M | -11.9 M | - | - | - | - | - |
Vermögenswerte |
208 M | 323 M | 246 M | 169 M | 129 M | 22 M | 18.3 M | - | - | - | - | - |
Zahlungsmittel |
32.7 M | 223 M | 94.2 M | 65.3 M | 48 M | - | - | - | - | - | - | - |
Buchwert |
141 M | 281 M | 237 M | 160 M | -85.7 M | -26.3 M | -11.9 M | - | - | - | - | - |
Gesamtes Eigenkapital |
141 M | 281 M | 237 M | 160 M | -85.7 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich TCR2 Therapeutics
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
2.71 M | 3.32 M | 37.7 M | 43.2 M | 36.8 M | 23 M | 23.6 M | 24 M | 35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
50.2 M | 67.4 M | 74.4 M | 81.8 M | 67.9 M | 41.9 M | 40.5 M | 39.2 M | 46.4 M | 9.65 M | 9.65 M | 9.65 M | 9.65 M | 8.08 M | 8.08 M | 8.08 M | 8.08 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-542 M | -501 M | -441 M | -410 M | -379 M | -350 M | -322 M | -296 M | -271 M | -250 M | -250 M | -250 M | -250 M | -183 M | -183 M | -183 M | -183 M | -85.6 M | -85.6 M | -85.6 M | -85.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
152 M | 208 M | 273 M | 308 M | 323 M | 323 M | 347 M | 368 M | 396 M | 246 M | 246 M | 246 M | 246 M | 169 M | 169 M | 169 M | 169 M | 129 M | 129 M | 129 M | 129 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
14.4 M | 32.7 M | 54 M | 44.2 M | 74.1 M | 223 M | 262 M | 249 M | 218 M | 94.7 M | 94.2 M | 94.2 M | 94.2 M | 65.3 M | 65.3 M | 65.3 M | 65.3 M | 47.7 M | 47.7 M | 47.7 M | 47.7 M | 20.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
101 M | 141 M | 199 M | 226 M | 255 M | 281 M | 306 M | 329 M | 350 M | 237 M | 237 M | 237 M | 237 M | 160 M | 160 M | 160 M | 160 M | 124 M | 124 M | 124 M | 124 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
101 M | 141 M | 199 M | 226 M | 255 M | 281 M | 306 M | 329 M | 350 M | 237 M | 237 M | 237 M | 237 M | 160 M | 160 M | 160 M | 160 M | -85.7 M | -85.7 M | -85.7 M | -85.7 M | -26.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung